Cambridge Consultants, a leading technology design and development firm, recently completed a comprehensive technical and commercial due diligence programme in support of Sphere Medical Holding plc’s listing on the AIM market of the London Stock Exchange.
Domainex Ltd., the UK-based drug discovery company focused on speed and innovation, has been awarded a £250,000 grant by the Technology Strategy Board – the UK’s national innovation agency – to help support the development of a new drug for the treatment of several common cancers.
News Archive
This news board lists the latest news from companies working on the Science Park.
Subscribe to our News RSS Feed
Founded in 1970 by
21 November 2011
Cambridge Consultants uses medtech expertise to help Sphere Medical achieve public listing
Cambridge Consultants, a leading technology design and development firm, recently completed a comprehensive technical and commercial due diligence programme in support of Sphere Medical Holding plc’s listing on the AIM market of the London Stock Exchange.
17 November 2011
Oval Medical Technologies receives £2 million investment from AptarGroup
Oval Medical Technologies Ltd., (“Oval”) the pioneering autoinjector development company, [...]
15 November 2011
Leadless pacemaker brings new hope to cardiac patients
Innovative product development eliminates pacing leads by stimulating the heart through wireless transmission of energy.
10 November 2011
Removal of ATM machine at Science Park
Barclays Bank have made the decision to remove their ATM [...]
9 November 2011
Traffic arrangements for the Cambridge Fun Run
The Cambridge Fun Run is due to be held at [...]
2011 Cambridge Fun Run
It’s time to get in training again – the Cambridge Fun Run will take place at the Cambridge Science Park on 18 November 2011.
8 November 2011
Domainex Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug
Domainex Ltd., the UK-based drug discovery company focused on speed and innovation, has been awarded a £250,000 grant by the Technology Strategy Board – the UK’s national innovation agency – to help support the development of a new drug for the treatment of several common cancers.